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ABSTRACT
Objective: This present study was aimed to evaluate the potential of chitosan succinate as a coating polymer.
Methods: In this study, chemical modification of chitosan was performed by substituting a succinate group into chitosan’s amine group. This reaction 
used a water-solvent method to obtain chitosan succinate. Chitosan succinate was characterized and used as a coating agent in enteric-coated tablet 
dosage forms containing sodium diclofenac as the drug model at concentrations of 3% and 4% and combined it with hydroxypropyl methylcellulose 
phthalate (HPMCP) in ratios of 3:1 and 2:1 (3%). The obtained tablets were evaluated based on their physical appearance, uniformity of weight and 
size, thickness film, disintegration time for an hour in acid, and dissolution profile.
Results: Although the enteric-coated tablets with 3% and 4% chitosan succinate dissolved after 1 h in acid, they could not hold drug release in the 
acid medium under 10%. The enteric-coated tablet combined with chitosan succinate and HPMCP (3:1 and 2:1) at 3% did not dissolve after 1 h in the 
acid medium and could hold drug release up to 8.53% in acid.
Conclusion: A combination of chitosan succinate and HPMCP (3:1 and 2:1) at 3% has a better ability to hold drug release in acid medium and met the 
requirement as a coating in enteric-coated tablet dosage forms.
Keywords: Enteric-coated tablet, Chitosan succinate, N-acylation chitosan, Sodium diclofenac.
INTRODUCTION
Application of coatings to the surface of pharmaceutical solid dosage forms, 
particularly tablets, has been practised for over 150 years [1]. Enteric-
coated tablets are used to prevent stomach irritation and a drug’s release 
into the stomach for the delivery of drugs to the intestine for absorption 
into the bloodstream [2]. Enteric-coated tablets supported by polymers 
have good stability in stomach fluids and dissolve well in the intestine [1].
Hydroxypropyl methylcellulose phthalate (HPMCP) and cellulose acetate 
succinate are common excipients used in enteric-coated tablets [3]. 
These are prepared from modified cellulose with dicarboxylic acid, 
such as phthalic or succinic acid. Group of carboxyl was substituted by 
hydroxyl group to increase its solubility because this group can ionize to 
become carboxylate ion with high solubility in alkaline [4].
Recently, many researchers attempted to modify chitosan to create a 
novel enteric-coated polymer. The amine functional group of chitosan 
can be modified using a substitution reaction under mild conditions, 
which is an added advantage along with its many other properties, such 
as biodegradability, non-toxicity, and non-immunogenicity. The amino 
group can be substituted with a dicarboxylic acid, such as phthalic or 
succinic acid. Chitosan succinate is created through substitution reaction 
with succinic acid. Being anionic, chitosan succinate has favorable 
characteristics for the oral delivery system and has wide solubility in 
alkaline media and decreased solubility in acid. The change in solubility 
occurs because of the decreased amount of amino group and substitution 
with carboxylic groups during the substitution reaction [5-8]. This 
characteristic indicates that modifying chitosan with succinic acid gives 
it the potential to be a useful polymer for enteric-coated tablets [9].
Adding a proton to chitosan’s amino group (NH3) changes the amino 
group to NH4+ and makes chitosan as a better solubility in acid medium. 
The loss of amino groups decreases chitosan solubility in acid and 
creates better solubility in alkaline [10,11]. In this research, we 
modified chitosan to create chitosan succinate through substitution 
reaction using succinic acid. The result was characterized by physical, 
chemical, and functional changes. Further, we created an enteric-coated 




Natrium diclofenac (Dipharma Francis, Italy), Primogel® (DMW 
International, the Netherland), Avicel® PH 102 (Mingtai Chemical, 
China), glycerol (Brataco, Indonesia), HPMCP (Shin-Etsu Chemical, 
Japan), PVP (BASF Chemical, German), Talc (Haichin, China), lactose 
anhydrate (DMW International, Netherland), and other reagents used 
were of analytical grade.
Chitosan succinate preparation
About 4 g of chitosan (deacetylated degree of 94.2%, Surindo Biotech, 
Indonesia) was dissolved in 400 ml of 1% acetic acid. Succinic 
anhydride (Merck, Germany) was dissolved in 400 ml of methanol and 
added into a beaker with the chitosan solution by dropping method. We 
increased the pH by adding 1.0 N NaOH until the solution neutralized 
and prepared the precipitated mixture. This mixture was then filtered to 
remove the solvent and was then washed with methanol. The precipitate 
was dialyzed for 24 h and dried at 40°C in an oven (Modena®) for 24 h. 
Then, the dried material was filtered with 60-mesh sieve.
Characterization
Physical appearance
The products were evaluated based on their shape, color, and odor.
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Observation of surface shape and morphology by scanning 
electron microscopy (SEM)
The shape and morphology of the surface were observed by SEM with 
the enlargement scales as ×200, ×500, ×1000, and ×5000.
Differential scanning calorimetry
Approximately 5 mg of samples were heated from 30°C to 250°C at a 
scanning rate of 10°C/min under a stream of nitrogen.
Solubility
Chitosan and chitosan succinate (50 mg) were dissolved into 10 ml 
of aquadest; 0.1% HCl, pH 1.2; HCl, pH 3; HCl, pH 5; phosphate buffer, 
pH 6.8; phosphate buffer, pH 7.4; and NaOH, pH 12 for 2 h on a shaker 
(200 rpm). The aliquots were filtered through a Whatman filter (0.2 µm) 
and spectrophotometrically assayed at 228 nm.
Degree of substitution (DS)
DS was determined by indirect titration with 1.0 N HCl until the samples 
showed color change from yellow to orange.
DS(mol/g) = 
[N V -N V ]
Chitosan succinate (g)
NaOH NaOH HCl HCl
Infrared analysis
IR spectra were obtained with Fourier-Transform Infrared Spectrometer 
8400 S (Shimadzu, Jepang) in the range 4000–400 cm−1.
Viscosity
Chitosan succinate was dispersed into 0.03% ammonium solution 
and made into a polymer concentration of 3% and 4%. Viscosity was 
measured with a Brookfield viscometer.
Swelling test
Approximately 100 mg of samples were formed as tablets and placed in 
20 ml of HCl solution (pH 1.2) and 20 ml of phosphate buffer (pH 6.8) 
at 37°C±0.5°C. The swelling index was determined after 15, 30, 60, 90, 
and 120 min. The swelling index was calculated by dividing (Dt–D0) 
with D0 then times 100%.
Where
Dt = diameter of tablet in t min and Do = diameter of dried tablet
Preparation of core tablets
Core tablets were prepared by direct compression method with a 
weight of 300 mg for each tablet (Table 1).
Preformulation testing
Preformulation testing was performed to determine bulk density, tapped 
density, Hausner’s ratio, angle of repose, and compressibility index.
Tablet hardness, diameter, thickness, weight variation, and friability 
test
These tests were performed according to the Indonesian Pharmacopeia 
(4th edition). The experiments were conducted with 20 tablets for 
friability and weight variation and 10 for all other tests. Mean value and 
standard deviations were calculated.
Disintegration test
One tablet was placed in each of the six tubes, and the disintegration 
tester was operated for an hour using HCl solution (pH 1.2) as the 
immersion fluid and maintained at 37°C±2°C.
Dissolution test
This test was performed using the United States Pharmacopeia (USP) 
type 1 apparatus (basket type) at 50 rpm at 37°C±0.5°C using HCl 
solution (pH 1.2) for first 2 h and continued 45 min within phosphate 
buffer (pH 6.8). Dissolution media samples (900 ml and 10 ml) were 
withdrawn at specific intervals and were analyzed at λ 276 nm [12].
Preparation of enteric-coated tablets
Core tablets were coated with different concentrations of chitosan 
succinate coating solution and used in combination with hydroxypropyl 
methylcellulose to increase their potential as an enteric polymer. The 
detailed compositions of the natrium diclofenac enteric-coated tablet 
formulations are given in Table 2.
Evaluation of enteric-coated tablets
Appearance
Color and shape were visually inspected before and following the 
coating process.
Film thickness
Radius and height of tablets were measured using a micrometer before 
and after coating. The differences were used to calculate film thickness.
Weight uniformity
Twenty enteric-coated tablets for each formulation were weighed 
before and after coating, and average weight was calculated. The 
average weight was used to calculate the increment of weight.
Disintegration test
One tablet was placed in each of the six tubes of the basket, and the 
disintegration test was operated for an hour using HCl solution (pH 1.2) 
as the immersion fluid and maintained at 37°C±2°C. After an hour, the 
basket was lifted from the fluid and each tablet was observed. The 
test was continued using phosphate buffer (pH 6.8) and operated for 
45 min.
In vitro drug release
This test was performed using USP type 1 apparatus (basket type) at 
50 rpm at 37°C±0.5°C using HCl solution (pH 1.2) for the first 2 h and 
continued for 45 min with phosphate buffer pH 6.8. Dissolution media 
samples (900 ml and 10 ml) were withdrawn at specific intervals and 
analyzed at λ 276 nm [12].




Avicel® PH 102 200
Primogel® 9
Talc 6
Table 2: Composition of enteric coating solutions
Ingredients Formulation (g)
Sealing F1 F2 F3 F4
Chitosan succinate - 3 4 2.25 2
HPMCP - - - 0.75 1
Glycerol - 0.9 1.2 0.9 0.9
PVP 3 - - - -
Ethanol 95% ad 100 - - - -
Ammonium solution 0.03% (v/v) ad - 100 100 100 100
PVP: Polyvinylpyrrolidone, F1: Coating solution chitosan succinate 3%, 
F2: Coating solution chitosan succinate 4%, F3: Coating solution chitosan 
succinate HPMCP (3:1) 3%, F4: Coating solution chitosan succinate 
HPMCP (2:1) 3%, Glycerol was 30% of total concentration of polymer for F1-F4, 
HPMCP: Hydroxypropyl methylcellulose phthalate
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RESULTS AND DISCUSSION
Characterization of chitosan succinate
The product was a odorless granular solid with  irregular shape and 
yellowish-white colour. The surface morphology of the chitosan 
succinate powder was coarse and rough. SEM image was not shown.
Differential scanning calorimetry measurements were performed 
to investigate changes in the physical state of the compounds. From 
the termogram, we concluded that the endothermic peak of chitosan 
succinate (79°C) differed from its origin polymer (82.4°C), and they 
also had different melting traces, wherein chitosan succinate was 
131.1°C and chitosan 122.7°C.
The obtained DS was 3.65 mol/g after 8 h. DS was influenced by the 
time needed for synthesis. Further increase of reaction time slightly 
promoted further succinylation reaction. In another research, 24 h was 
the optimum reaction time to obtain high DS of the product [10,13]. 
The materials dissolved in the acidic region at pH 1.2 and alkaline region 
(from phosphate buffer medium to pH 12 medium), but it did not dissolve 
in aquadest. The solubility in the acidic region could be caused by the 
protonation of the N-amino groups (–NH2 to –NH3+), and the solubility 
in the basic region could be caused by the change of the carboxyl groups 
to carboxylate ions (–COOH to –COO) [4,14,15]. On the other hand, the 
solubility in aquadest was caused by its lower DS, which was 3.65 mol/g. 
The greater DS showed the greater solubility in aquadest [6].
The IR spectra of prepared chitosan succinate showed stretching at 
1670.41 cm−1 for –C=O and 1541.18 cm−1 for –NH– in amide bonding, 
whereas the stretching at 1585.54 cm−1 –C=O for amine decreased [16]. 
The stretching for carboxylic carbonyl was not clearly seen because the 
DS was too low (3.65 mol/g).
The results of the swelling index test of chitosan succinate in the acid 
medium (126.6%) showed that swelling was lower than that of the origin 
polymer. In the alkaline medium, chitosan succinate showed swelling 
ability, but the ability was too low (16.1% after 45 min). However, it was 
higher than chitosan, which did not have swelling ability in the alkaline 
medium. Chitosan succinate had a charged carboxyl, which was ionized 
in phosphate buffer; hence, an osmotic pressure gradient occurred and 
caused transferal of water and materials into the polymer.
Viscosity measurements were conducted on chitosan succinate using an 
aqueous solution of ammonium 0.03% (w/v) as a solvent. Flow properties 
of chitosan did not change much when it was modified into chitosan 
succinate. Tests were performed on chitosan succinate concentrations of 
3% and 4%. Based on the test results, it can be concluded that chitosan 
succinate showed flow properties of pseudoplastics.
An increased concentration of chitosan succinate caused the increased 
viscosity of the medium. A rheogram is used to show the force per unit 
area (shearing stress) of the molecules of long-chain materials. With 
increasing shearing stress, the molecules begin drafting in the direction 
of flow. This reduces the resistance in the direction of the material, 
and the resulting differences in terms of velocity (rate of shear) were 
greater for every subsequent shearing stress [17].
Core tablet evaluation
Core tablet evaluation included appearance, diameter, thickness, weight 
variation, hardness, friability, and disintegration (Table 3).
Dissolution test of core tablets
The amount of natrium diclofenac released was measured using a 
calibration curve made of natrium diclofenac with dissolved phosphate 
buffer (pH 6.8). The calibration curve was calculated using the following 
equation: y=0.00357+0.02818x with r=0.99992.
The dissolution test was conducted using regression linear method, 
using phosphate buffer for dilution, causing sodium diclofenac to 
undergone intramolecular cyclization under acidic conditions, and 
making it immeasurable. The result of the dissolution test observed 
was 105.48±2.73%.
Evaluation of preparation coating solution
Medium preparation was performed on six coating formulations of 
chitosan succinate medium at 3%, 4%, and 5%, and three formulations 
of chitosan succinate combined with HPMCP were chitosan succinate-
HPMCP (3:1) 3%, chitosan succinate-HPMCP (2:1) 3%, and chitosan 
succinate-HPMCP (3:1) 4%. Each plasticizer formulation used the same 
percentage as the polymer (30%). The coating solution that was made 
was further tested for viscosity using a Brookfield viscometer. The 
succinate chitosan coating solution 3% and 4% and the combination of 
chitosan succinate-HPMCP (3:1 and 2:1) with the total concentration of 
3% showed the following results, respectively: Viscosity 1825.7, 2775.5, 
1809.4, and 1491 cps. The coating solution with a concentration of 
5% chitosan succinate and chitosan succinate-HPMCP (3:1) 4% could 
not flow; therefore, no viscosity measurements were taken, and these 
solutions did not proceed to the coating process. Coating solution with 
a concentration of 4% chitosan succinate had the highest viscosity 
compared with other coating solutions. A greater concentration would 
increase the viscosity of the solution [17]. Coating with a combination 
solution of chitosan succinate-HPMCP (3:1) of 3% had a greater viscosity 
than the combination of chitosan succinate (2:1) 3%, indicating that the 
addition of HPMCP did not increase the viscosity of the coating solution. 
Based on these preliminary studies, there are several ideal formulations 
of coating medium, i.e. coating medium made of chitosan succinate 3%, 
coating medium made of chitosan succinate 4%, coating medium made 
of combination of chitosan succinate-HPMCP (3:1) 3%, and coating 
medium made of chitosan succinate-HPMCP (2:1) 3%.
Evaluation of enteric-coated tablets
Evaluation included the appearance of coated tablets, thickness of film, 
weight uniformity, disintegration, and dissolution tests. All the tablets 
Table 3: Evaluation of core tablets
Parameter Result






Disintegration 5.49±0.41 min (5 min 30 s)
Fig. 1: Dissolution profiles of the core tablets and the enteric-
coated tablets of F1–F4 in HCl solution pH 1.2 for 2 h and 
phosphate buffer solution pH 6.8 for 45 min. Each point 
represents the mean ± SD (n=3)
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were coated with the coating solution. F1–F4 coated surface results 
were smooth and not shiny. Smooth-coated surfaces may be obtained 
with a good drying process. The color-coated tablet was different from 
the white F1. F2–F4 were brown because of the resulting polymers’ 
different colors.
Uniformity of size results showed that the F2 coated tablet was 
4.478 mm thick and 9.063 mm in diameter. The F2 coated tablet was 
greater than F1, F3, and F4, with thicknesses of 4.453, 4.449, and 
4.439 mm, respectively, and diameters of 9.048, 9.038, and 9.031 mm, 
respectively. The coated tablets F1, F3, and F4 had the same sodium 
diclofenac concentration (3%) and showed differences in terms of 
diameter and thick-coated tablets. F1’s diameter and thickness were 
greater than the tablets coated with F3 and F4. The combination of 
coated tablet formulations F3 and F4 showed that F3 had a thickness 
and a diameter greater than those of F4. F1–F4 coated tablets had a 
value of the coefficient of variation below 2% and met the parameters 
of uniformity.
Differences in terms of thickness and diameter of coated tablets can be 
caused by the concentration and viscosity of the coating medium. The 
greater the concentration of the polymer coating used, the greater the 
viscosity of the coating medium [18]. The F2 coated tablet had a greater 
concentration, resulting in a much greater thickness and diameter. The 
greatest viscosity was shown in F2 medium (2775.5 cps). Coated tablets 
F1, F3, and F4 had the same concentration but different viscosities. 
The medium viscosity coating, F1, has a value greater than F3 and 
F4 (1825.7 cps). The medium viscosity coating F3 was 1809.4 cps and 
F4 was 1491 cps. Viscosity is influenced by diameter and thickness of 
coated tablets. This is evident from the difference in terms of viscosity 
formulations with the same polymer concentration in F1, F3, and F4. 
Viscosity difference is caused by a reduction in the amount of chitosan 
succinate that is replaced HPMCP. The results are shown in Table 4.
Coating thickness was measured using data uniformity, coated tablet 
thickness, and diameter of each formulation. Table 3 shows the 
thickness of the coated tablets in each coated tablet formulation.
The F2 coated tablet had the largest thickness interval among all the 
coated tablets, caused by the concentration of chitosan succinate 
used (4%). Meanwhile, the combination of chitosan succinate tablets 
coated with HPMCP showed that the F3 coated tablets produced 
a greater thickness than the F4 tablets. The F1 coated tablet had a 
coating thickness greater than F3 and F4 tablets. Coating thickness is 
influenced by the concentration of polymer used and the viscosity of 
the coating solution [19].
The F2 coated tablet demonstrated the greatest weight increment 
(5.87%). F1, F3, and F4 demonstrated a similar weight increment 
(4.31%, 4.96%, and 4.54%, respectively). Coated tablet weight gain can 
increase the containment of drug release in acidic conditions, and an 
increase in weight of >5% is not eligible for coated tablets. F2 coated 
tablets did not qualify as a coated layer tablet due to their increase in 
weight (exceeding 5%).
Increase in weight is influenced by the concentration of polymer and 
plasticizer used. Increasing the concentration of the polymer affects the 
viscosity of the coating solution to increase its viscosity. The increase in 
weight of a coated tablet may also be affected by the spraying technique 
and the amount of coating solution. The amount of coating may vary in 
each spray.
Disintegration test
Based on the results of the disintegration test, the F1 coated tablet 
could not be used as a coating polymer because tablets were softened 
after an hour in HCl solution (pH 1.2). F2–F4 coated tablets were better 
able to survive in a physical form in the acidic fluid for 1 h. This result is 
due to the presence of enteric polymer HPMCP, which allows the coated 
layer to survive well in acidic conditions.
Second, coated tablets were tested in an alkaline medium for 45 min. 
F2 coated tablets were disintegrated in alkaline after 20 min 57 s and 
longer than F3 (19 min 7 s) and F4 (17 min 45 s) coated tablets.
Dissolution test
Based on the dissolution profiles of sodium diclofenac-coated tablets 
in Fig. 1, F1 and F2 coated tablets were not able to resist drug release 
in the acidic media because the release of the acid was above 10%, 
which is approximately 32.37% and 17%, respectively. According to 
Indonesia Pharmacopeia 4th, enteric coated preparations meet the 
requirements if the drug release in pH 1.2 HCl medium is under 10%. 
Coated tablets F3 and F4 showed better results with the release of 
diclofenac sodium in the acidic medium under 10%: 8.53% and 6.74%, 
respectively. The chitosan succinate enteric coating in these tablets 
was combined with the enteric polymer HPMCP to improve the quality 
of the coated tablets.
The results of the drug release of tablets F1 and F2 after dissolution 
for 45 min in pH 6.8 phosphate medium show that the cumulative 
amount of dissolved drug reaches 102.99% and 96.80%, respectively. 
On the other hand, F3 and F4 obtained a cumulative total of 93.48% and 
91.97%, respectively. The release of diclofenac sodium in phosphate 
medium (pH 6.8) cannot be separated from the increase of chitosan 
succinate solubility in alkali. The F3 and F4 coated tablets met the 
requirements of cumulative release in alkaline medium, because they 
released the drug more than 80% in alkaline medium.
Based on this study, chitosan succinate was successfully synthesized 
using the aquaeous method. DS of chitosan succinate obtained was 
3.65 mol/g with the expansion of solubility in the alkaline medium. 
Chitosan succinate was subsequently used as a coating with four 
formulations, namely F1–F4. Formulations F1 and F2 could not 
be used as a coating material on enteric-coated tablets, because 
they could not resist drug release in acid medium lower than 10%. 
However, formulation F3 and F4, which were combined with HPMCP 
25% and 33% of coating polymers, could resist drug release in acidic 
medium, subsequently release the drug more than 80% in alkaline 
medium.
CONCLUSION
The produced chitosan succinate had DS value of 3.65 mol/g and 
enhanced solubility in alkaline conditions. The enteric-coated tablets, 
which had been coated with a mixed polymers of chitosan succinate 
Table 4:  Evaluation of the enteric-coated tablets
Evaluations Sealing (PVP 3%) F1 F2 F3 F4
Thickness (mm) 4.423±0.001 4.453±0.001 4.478±0.0016 4.449±0.0002 4.439±0.002
Diameter (mm) 9.015±0.0022 9.048±0.002 9.063±0.001 9.038±0.002 9.031±0.001
Weight (mg) 309.3±0.32 322.1±0.86 327.6±0.59 322.8±1.02 322.4±1.12
Increase in weight (%) 2.19% 4.31% 5.87% 4.96% 4.54%
Disintegration time in acidic medium (min) Dissolved Dissolved Undissolved Undissolved Undissolved
Disintegration time in alkaline medium (min) - 20.95±1.88 19.11±0.12 17.75±1.29
% Dissolution in acidic medium for 2 h - 32.39±0.61 17.00±1.08 8.53±0.89 6.74±1.16
% Dissolution in alkaline medium for 45 min - 102.99±1.20 96.80±2.45 93.48±3.55 91.97±2.97
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and HPMCP (3:1) and (2:1), could withstand drug release <10% in acid 
medium and extend the drug released in alkaline medium >80%, so it 
meets the requirements of an enteric-coated tablet.
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